How much is the latest price of neratinib (neratinib) per box in 2024?

Neratinib (Neratinib) is an oral targeted therapy drug mainly used to treat HER2 positive breast cancer. HER2 (human epidermal growth factor receptor 2) is a protein overexpressed on the surface of some cancer cells, where it promotes their growth and division. HER2positive breast cancer is a relatively common cancer subtype characterized by abnormal overexpression of the HER2 protein.

Neratinib (neratinib) has been launched in China and has been included in medical insurance. Patients can buy it domestically at a price of about 7,000 to 8,000 yuan. Please consult the local hospital pharmacy for specific prices and medical insurance reimbursement policies. The cheaper ones abroad are Bangladeshi generic drugs. The price is about more than 3,000 yuan, which is about half cheaper than domestic drugs. The ingredients of domestic drugs are basically the same.

Neratinib belongs to a class of drugs called tyrosine kinase inhibitors. It blocks the growth and spread of tumor cells by inhibiting the kinase activity in theHER2receptor and its downstream signaling pathways. This medication is an oral medication that is usually available in tablet form that patients can take at the convenience of their home.

Clinical studies have shown that neratinib (neratinib) has certain efficacy in the treatment of early HER2 positive breast cancer and advanced or metastatic HER2positive breast cancer. It can be used as adjuvant therapy in patients with newly diagnosed early-stage breast cancer to reduce the risk of cancer recurrence. For patients with advanced or metastatic breast cancer, neratinib (neratinib) can be used as a first-line treatment or follow-up treatment option to help control tumor progression and extend patient survival.

However, it is important to note thatneratinib may cause some side effects, including diarrhea, nausea, vomiting, fatigue, rash, etc. Some patients may experience serious side effects, such as liver function abnormalities, lung toxicity, etc. Therefore, during treatment with neratinib (neratinib), patients need to closely monitor their body's response and maintain close communication with medical professionals so that treatment options can be adjusted in a timely manner.